POET Technologies: A Tightened Bench, a Fresh Order, and a Market Still Waiting for Proof

POET's Q2 revenue rose 112% YoY, but shares fell 66% from May high. New board, orders, and cash position signal growth ahead of market sentiment.

The stock chart tells one story — a 66% slide from May's 52-week high of €18.84 to a recent close of €6.43. But the operational narrative at POET Technologies has been moving in a different direction entirely, and the gap between the two is where the real tension lies.

A Board Rebuilt for the Scaling Phase

Early August brought a governance overhaul that signals a shift in priorities. Dr. Bardia Pezeshki and Jean F. Rankin joined the board of directors on August 1, replacing Jean-Louis Malinge, who stepped down for personal reasons. The appointments carry genuine weight: Pezeshki, a founder and former CEO or CTO of Avicena Tech, Kaiam, and Santur, brings deep expertise in optical communications and semiconductor technology — precisely the domain where POET's Optical Interposer platform competes. Rankin contributes governance and legal experience accumulated across stints at InterDigital, Resonant, LSI, and Agere.

Both directors received 21,460 restricted stock units vesting through June 2027 — an incentive structure designed for the long haul rather than quick exits. The timing matters: this is a board being positioned for manufacturing scale-up and capital markets discipline, not just R&D oversight.

That governance work was preceded by an operational appointment back in May, when Dr. Sandeep Kumar took over as chief operating officer. The early reinforcement of the operational layer now looks prescient given what the second-quarter numbers, reported mid-August, revealed.

The Numbers Behind the Narrative

Revenue reached $569,925 in Q2, up 13% sequentially and 112% year over year — the sixth consecutive quarter of sequential growth. The net loss narrowed to $11.3 million from $12.3 million in Q1. With $796.3 million in cash following the $400 million capital raise completed in May, the company appears well-funded to execute its production ramp without an imminent return to the equity markets.

That cash position also contextualizes the recent order flow. A $2.4 million purchase order from an existing customer — notable because it signals a recurring relationship rather than a one-off trial — arrived alongside a development agreement with an unnamed tier-one laser manufacturer for an external light source engine, a component relevant to optical interconnect solutions in data centers. These announcements followed the quarterly report and fit into a broader pattern of operational milestones, including the May agreement with Lumilens covering an initial $50 million volume that could expand to over $500 million across five years.

Why the Stock Isn't Cooperating

The market has yet to reward any of this. The shares trade roughly 12% below their 50-day moving average of €7.25, recently at €6.36, and have shed 8.1% over the past seven trading sessions. The stock sits about 9.0% below its 200-day average with annualized volatility of 96% — a figure that captures the nervousness endemic to semiconductor growth names.

No single catalyst explains the recent 2.0% daily decline; it reads more as a continuation of consolidation following a twelve-month run that still leaves the stock up 39%. The board's mid-August decision to shelve the previously announced relocation of the corporate headquarters to the United States may have added to the uncertainty, with some observers interpreting the reversal as strategic indecision.

September as the Decisive Test

The company has flagged September for further announcements, and management's guidance points to initial production volumes being shipped for customer qualification in the remaining quarters of 2026. Whether the coming weeks deliver a visibly larger order book or concrete delivery timelines will likely determine if the stock can break free from its current range.

For now, the picture is one of operational progress running ahead of market sentiment. The recent order and partnership news provide tangible evidence of commercial traction, even if their scale remains modest relative to the company's cash reserves. The personnel moves — Kumar in operations, Pezeshki and Rankin in the boardroom — suggest an organization preparing itself to deliver on its production promises. The volatility will persist until the proof arrives. But the foundation being laid looks sturdier than the recent price action implies.